Data Notes for the Week of July 15
Read Data Snapshot
If you’re new to the data snapshot, we publish a weekly summary of the status for each of our metrics (you can find past issues on our data and dashboard page). The data below are from June 28 – July 11.
Cases were stable during this 14-day period with an average of 10 cases per day.
We had a low percent positivity of 0.9% and conducted an average of 1,074 tests per day. The number of people hospitalized in Dane County hospitals with COVID is increasing, but the 14-day average of 20 people hospitalized is still among the lowest levels we’ve had since May 2020. We are not able to discern whether these hospitalizations are among Dane County residents or among patients transferred to one the Dane County hospitals from surrounding areas.
It’s been more than seven weeks since we’ve had a death due to COVID.
81% of our most recent sequenced cases have been the Delta variant of concern. It is likely that Delta is now the dominant strain of virus in Dane County.
Of 26 cases sequenced in the most recent two-week period, 21 (81%) were Delta. The Delta variant is concerning because it has increased transmissibility, and antibodies produced in response to COVID-19 infection or partial vaccine may be less effective in fighting the virus. The COVID-19 vaccines available in the U.S. have shown to still provide protection against the Delta variant, particularly in preventing severe disease and death. We have very good vaccine coverage in Dane County, including a high percentage of people who have completed the series (see next section).
The most effective way to protect yourself and our community from being impacted by this variant is to get vaccinated. See our website for locations on where to get vaccinated.
80.2% of the eligible population (ages 12+) have received at least one dose of vaccine.
69.4% of Dane County residents have received at least one dose of vaccine and 66.7% have completed the vaccine series. 80.2% of the eligible population (ages 12+) have received at least one dose of vaccine and 77.1% have completed the vaccine series.